signalz.pro

Subscription: Free

  • BUY : TATAMOTORS-EQ( TATAMOTORS ) [3456]

    —

    by

    Tata Motors Limited shows strong growth potential driven by its leadership in electric vehicles ⚡, robust SUV portfolio 🚙, and global presence 🌍 through Jaguar Land Rover. The company’s ongoing restructuring aims to unlock higher operational efficiency and enhance shareholder value. Domestic demand for PVs and CVs remains healthy, supported by infrastructure spending and EV…

  • BUY : SHAILY-EQ( SHAILY ) [8727]

    —

    by

    TECHNICALLY BULISH WITH GOOD VOLUME

  • BUY : SAILIFE-EQ( SAILIFE ) [27839]

    —

    by

  • BUY : KOTAKBANK-EQ( KOTAKBANK ) [1922]

    —

    by

    Kotak Bank is in a short-term downtrend, trading below key EMAs with MACD negative and Parabolic SAR signaling bearishness. RSI near oversold (~32) may allow a brief bounce, but strong resistance lies near ₹2020, while support is at ₹1950–₹1940 and ₹1900. Bias remains bearish unless price sustains above ₹2020.

  • BUY : SUNPHARMA-EQ( SUNPHARMA ) [3351]

    —

    by

    SUNPHARMA has seen a sharp fall from ₹1740 to ₹1580, staying below all key moving averages, indicating weakness. MACD and Parabolic SAR remain bearish, while RSI at 36 signals it’s near oversold, hinting at a possible brief bounce. Support is at ₹1560–₹1550 and ₹1520, with resistance at ₹1660–₹1700.

  • BUY : BANKNIFTY28AUG2555600CE( BANKNIFTY ) [66839]

    —

    by

    TECHNICALLY BULISH

  • BUY : NIFTY14AUG2524450CE( NIFTY ) [44470]

    —

    by

    TECHNICALLY BULISH

  • BUY : BANKNIFTY28AUG2555500CE( BANKNIFTY ) [66788]

    —

    by

    Technical Outlook As we can see in 15 minute candle stick chart of BANK NIFTY, during the Q1 result of SBIN its volatizing but holding the support around 55300 in future, short term Parabolic SAR & MACD is also supporting for reversal around this level, hence can see a pullback in it around this level.

  • BUY : FORTIS-EQ( FORTIS ) [14592]

    —

    by

    Fortis Healthcare Limited has shown a strong turnaround in Q1 FY26, reporting a net profit of ₹5,188 lakhs compared to a loss of ₹4,223 lakhs in the previous quarter, indicating robust operational recovery. The company continues to benefit from increased patient footfall, improved occupancy rates, and expanding diagnostic services. Backed by IHH Healthcare Berhad, Fortis…

  • BUY : PGEL-EQ( PGEL ) [25358]

    —

    by

    PGEL is currently in a long-term downtrend, consistently making lower highs and lower lows since April 2025. It recently broke a key support near ₹750 with strong volume, indicating increased selling pressure. The next major support lies around ₹700–₹680. With earnings scheduled tomorrow, the stock’s direction will largely depend on the results. A strong recovery…